7L9P image
Deposition Date 2021-01-04
Release Date 2021-03-03
Last Version Date 2025-05-28
Entry Detail
PDB ID:
7L9P
Keywords:
Title:
Structure of human SHLD2-SHLD3-REV7-TRIP13(E253Q) complex
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
3.60 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Pachytene checkpoint protein 2 homolog
Gene (Uniprot):TRIP13
Mutagens:E253Q
Chain IDs:A, B, C, D, E, F
Chain Length:432
Number of Molecules:6
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Mitotic spindle assembly checkpoint protein MAD2B
Gene (Uniprot):MAD2L2
Chain IDs:G, H (auth: I), I (auth: J), J (auth: K)
Chain Length:211
Number of Molecules:4
Biological Source:Homo sapiens
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Shieldin complex subunit 2, Shieldin complex subunit 3 chimera
Gene (Uniprot):SHLD3, SHLD2
Chain IDs:K (auth: Y), L (auth: X)
Chain Length:99
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Molecular mechanisms of assembly and TRIP13-mediated remodeling of the human Shieldin complex.
Proc.Natl.Acad.Sci.USA 118 ? ? (2021)
PMID: 33597306 DOI: 10.1073/pnas.2024512118

Abstact

The Shieldin complex, composed of REV7, SHLD1, SHLD2, and SHLD3, protects DNA double-strand breaks (DSBs) to promote nonhomologous end joining. The AAA+ ATPase TRIP13 remodels Shieldin to regulate DNA repair pathway choice. Here we report crystal structures of human SHLD3-REV7 binary and fused SHLD2-SHLD3-REV7 ternary complexes, revealing that assembly of Shieldin requires fused SHLD2-SHLD3 induced conformational heterodimerization of open (O-REV7) and closed (C-REV7) forms of REV7. We also report the cryogenic electron microscopy (cryo-EM) structures of the ATPγS-bound fused SHLD2-SHLD3-REV7-TRIP13 complexes, uncovering the principles underlying the TRIP13-mediated disassembly mechanism of the Shieldin complex. We demonstrate that the N terminus of REV7 inserts into the central channel of TRIP13, setting the stage for pulling the unfolded N-terminal peptide of C-REV7 through the central TRIP13 hexameric channel. The primary interface involves contacts between the safety-belt segment of C-REV7 and a conserved and negatively charged loop of TRIP13. This process is mediated by ATP hydrolysis-triggered rotatory motions of the TRIP13 ATPase, thereby resulting in the disassembly of the Shieldin complex.

Legend

Protein

Chemical

Disease

Primary Citation of related structures